blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3325000

EP3325000 - TREATMENT OF COGNITIVE IMPAIRMENT OF MUCOPOLYSACCHARIDOSIS TYPE IIIA BY INTRATHECAL DELIVERY OF HEPARAN N-SULFATASE [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  27.08.2021
Database last updated on 26.06.2024
FormerThe patent has been granted
Status updated on  18.09.2020
FormerGrant of patent is intended
Status updated on  29.04.2020
FormerExamination is in progress
Status updated on  18.01.2019
FormerRequest for examination was made
Status updated on  27.04.2018
FormerThe international publication has been made
Status updated on  27.01.2017
Most recent event   Tooltip14.06.2024Lapse of the patent in a contracting state
New state(s): TR		published on 17.07.2024 [2024/29]
Applicant(s)For all designated states
Shire Human Genetic Therapies, Inc.
300 Shire Way
Lexington, MA 02421 / US
[2018/22]
Inventor(s)01 / HASLETT, Patrick Anthony, John
2 Benton Road
Apt. 1
Somerville, MA 02143 / US
 [2018/22]
Representative(s)Carpmaels & Ransford LLP
One Southampton Row
London WC1B 5HA / GB
[2018/22]
Application number, filing date16745951.020.07.2016
[2018/22]
WO2016US43142
Priority number, dateUS201562194695P20.07.2015         Original published format: US 201562194695 P
[2018/22]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2017015375
Date:26.01.2017
Language:EN
[2017/04]
Type: A1 Application with search report 
No.:EP3325000
Date:30.05.2018
Language:EN
The application published by WIPO in one of the EPO official languages on 26.01.2017 takes the place of the publication of the European patent application.
[2018/22]
Type: B1 Patent specification 
No.:EP3325000
Date:21.10.2020
Language:EN
[2020/43]
Search report(s)International search report - published on:EP26.01.2017
ClassificationIPC:A61K38/46, A61P43/00
[2018/22]
CPC:
A61K38/46 (EP,US); A61K9/0019 (US); A61P3/00 (EP,US);
C12Y310/01001 (EP,US)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2018/22]
Extension statesBA19.02.2018
ME19.02.2018
Validation statesMA19.02.2018
MD19.02.2018
TitleGerman:BEHANDLUNG DER KOGNITIVEN BEEINTRÄCHTIGUNG VON MUCOPOLYSACCHARIDOSE TYP IIIA DURCH INTRATHEKALE VERABREICHUNG VON HEPARAN-N-SULFATASE[2018/22]
English:TREATMENT OF COGNITIVE IMPAIRMENT OF MUCOPOLYSACCHARIDOSIS TYPE IIIA BY INTRATHECAL DELIVERY OF HEPARAN N-SULFATASE[2018/22]
French:TRAITEMENT D'UNE DÉFICIENCE COGNITIVE DE LA MUCOPOLYSACCHARIDOSE DE TYPE IIIA PAR ADMINISTRATION INTRATHÉCALE D'HÉPARANE N-SULFATASE[2018/22]
Entry into regional phase19.02.2018National basic fee paid 
19.02.2018Designation fee(s) paid 
19.02.2018Examination fee paid 
Examination procedure19.02.2018Amendment by applicant (claims and/or description)
19.02.2018Examination requested  [2018/22]
19.02.2018Date on which the examining division has become responsible
22.01.2019Despatch of a communication from the examining division (Time limit: M06)
22.07.2019Reply to a communication from the examining division
23.09.2019Despatch of a communication from the examining division (Time limit: M04)
31.01.2020Reply to a communication from the examining division
30.04.2020Communication of intention to grant the patent
10.09.2020Fee for grant paid
10.09.2020Fee for publishing/printing paid
10.09.2020Receipt of the translation of the claim(s)
Divisional application(s)EP20199664.2  / EP3827839
Opposition(s)22.07.2021No opposition filed within time limit [2021/39]
Fees paidRenewal fee
24.07.2018Renewal fee patent year 03
22.07.2019Renewal fee patent year 04
22.07.2020Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU20.07.2016
AL21.10.2020
AT21.10.2020
CY21.10.2020
CZ21.10.2020
DK21.10.2020
EE21.10.2020
ES21.10.2020
FI21.10.2020
HR21.10.2020
IT21.10.2020
LT21.10.2020
LV21.10.2020
MC21.10.2020
MK21.10.2020
NL21.10.2020
PL21.10.2020
RO21.10.2020
RS21.10.2020
SE21.10.2020
SI21.10.2020
SK21.10.2020
SM21.10.2020
TR21.10.2020
BG21.01.2021
NO21.01.2021
GR22.01.2021
IS21.02.2021
PT22.02.2021
IE20.07.2021
LU20.07.2021
[2024/29]
Former [2024/22]HU20.07.2016
AL21.10.2020
AT21.10.2020
CY21.10.2020
CZ21.10.2020
DK21.10.2020
EE21.10.2020
ES21.10.2020
FI21.10.2020
HR21.10.2020
IT21.10.2020
LT21.10.2020
LV21.10.2020
MC21.10.2020
MK21.10.2020
NL21.10.2020
PL21.10.2020
RO21.10.2020
RS21.10.2020
SE21.10.2020
SI21.10.2020
SK21.10.2020
SM21.10.2020
BG21.01.2021
NO21.01.2021
GR22.01.2021
IS21.02.2021
PT22.02.2021
IE20.07.2021
LU20.07.2021
Former [2023/30]HU20.07.2016
AL21.10.2020
AT21.10.2020
CY21.10.2020
CZ21.10.2020
DK21.10.2020
EE21.10.2020
ES21.10.2020
FI21.10.2020
HR21.10.2020
IT21.10.2020
LT21.10.2020
LV21.10.2020
MC21.10.2020
NL21.10.2020
PL21.10.2020
RO21.10.2020
RS21.10.2020
SE21.10.2020
SI21.10.2020
SK21.10.2020
SM21.10.2020
BG21.01.2021
NO21.01.2021
GR22.01.2021
IS21.02.2021
PT22.02.2021
IE20.07.2021
LU20.07.2021
Former [2023/29]HU20.07.2016
AL21.10.2020
AT21.10.2020
CZ21.10.2020
DK21.10.2020
EE21.10.2020
ES21.10.2020
FI21.10.2020
HR21.10.2020
IT21.10.2020
LT21.10.2020
LV21.10.2020
MC21.10.2020
NL21.10.2020
PL21.10.2020
RO21.10.2020
RS21.10.2020
SE21.10.2020
SI21.10.2020
SK21.10.2020
SM21.10.2020
BG21.01.2021
NO21.01.2021
GR22.01.2021
IS21.02.2021
PT22.02.2021
IE20.07.2021
LU20.07.2021
Former [2022/35]AL21.10.2020
AT21.10.2020
CZ21.10.2020
DK21.10.2020
EE21.10.2020
ES21.10.2020
FI21.10.2020
HR21.10.2020
IT21.10.2020
LT21.10.2020
LV21.10.2020
MC21.10.2020
NL21.10.2020
PL21.10.2020
RO21.10.2020
RS21.10.2020
SE21.10.2020
SI21.10.2020
SK21.10.2020
SM21.10.2020
BG21.01.2021
NO21.01.2021
GR22.01.2021
IS21.02.2021
PT22.02.2021
IE20.07.2021
LU20.07.2021
Former [2022/23]AL21.10.2020
AT21.10.2020
CZ21.10.2020
DK21.10.2020
EE21.10.2020
ES21.10.2020
FI21.10.2020
HR21.10.2020
IT21.10.2020
LT21.10.2020
LV21.10.2020
MC21.10.2020
NL21.10.2020
PL21.10.2020
RO21.10.2020
RS21.10.2020
SE21.10.2020
SI21.10.2020
SK21.10.2020
SM21.10.2020
BG21.01.2021
NO21.01.2021
GR22.01.2021
IS21.02.2021
PT22.02.2021
LU20.07.2021
Former [2022/18]AL21.10.2020
AT21.10.2020
CZ21.10.2020
DK21.10.2020
EE21.10.2020
ES21.10.2020
FI21.10.2020
HR21.10.2020
IT21.10.2020
LT21.10.2020
LV21.10.2020
MC21.10.2020
NL21.10.2020
PL21.10.2020
RO21.10.2020
RS21.10.2020
SE21.10.2020
SI21.10.2020
SK21.10.2020
SM21.10.2020
BG21.01.2021
NO21.01.2021
GR22.01.2021
PT22.02.2021
Former [2022/10]AL21.10.2020
AT21.10.2020
CZ21.10.2020
DK21.10.2020
EE21.10.2020
ES21.10.2020
FI21.10.2020
HR21.10.2020
IT21.10.2020
LT21.10.2020
LV21.10.2020
NL21.10.2020
PL21.10.2020
RO21.10.2020
RS21.10.2020
SE21.10.2020
SI21.10.2020
SK21.10.2020
SM21.10.2020
BG21.01.2021
NO21.01.2021
GR22.01.2021
PT22.02.2021
Former [2021/50]AL21.10.2020
AT21.10.2020
CZ21.10.2020
DK21.10.2020
EE21.10.2020
ES21.10.2020
FI21.10.2020
HR21.10.2020
IT21.10.2020
LT21.10.2020
LV21.10.2020
NL21.10.2020
PL21.10.2020
RO21.10.2020
RS21.10.2020
SE21.10.2020
SI21.10.2020
SK21.10.2020
SM21.10.2020
BG21.01.2021
NO21.01.2021
GR22.01.2021
IS21.02.2021
PT22.02.2021
Former [2021/48]AL21.10.2020
AT21.10.2020
CZ21.10.2020
DK21.10.2020
EE21.10.2020
ES21.10.2020
FI21.10.2020
HR21.10.2020
IT21.10.2020
LT21.10.2020
LV21.10.2020
NL21.10.2020
PL21.10.2020
RO21.10.2020
RS21.10.2020
SE21.10.2020
SK21.10.2020
SM21.10.2020
BG21.01.2021
NO21.01.2021
GR22.01.2021
IS21.02.2021
PT22.02.2021
Former [2021/45]AL21.10.2020
AT21.10.2020
CZ21.10.2020
DK21.10.2020
EE21.10.2020
ES21.10.2020
FI21.10.2020
HR21.10.2020
LT21.10.2020
LV21.10.2020
NL21.10.2020
PL21.10.2020
RO21.10.2020
RS21.10.2020
SE21.10.2020
SK21.10.2020
SM21.10.2020
BG21.01.2021
NO21.01.2021
GR22.01.2021
IS21.02.2021
PT22.02.2021
Former [2021/37]AT21.10.2020
CZ21.10.2020
DK21.10.2020
EE21.10.2020
ES21.10.2020
FI21.10.2020
HR21.10.2020
LT21.10.2020
LV21.10.2020
NL21.10.2020
PL21.10.2020
RO21.10.2020
RS21.10.2020
SE21.10.2020
SK21.10.2020
SM21.10.2020
BG21.01.2021
NO21.01.2021
GR22.01.2021
IS21.02.2021
PT22.02.2021
Former [2021/36]AT21.10.2020
CZ21.10.2020
EE21.10.2020
ES21.10.2020
FI21.10.2020
HR21.10.2020
LT21.10.2020
LV21.10.2020
NL21.10.2020
PL21.10.2020
RO21.10.2020
RS21.10.2020
SE21.10.2020
SK21.10.2020
SM21.10.2020
BG21.01.2021
NO21.01.2021
GR22.01.2021
IS21.02.2021
PT22.02.2021
Former [2021/35]AT21.10.2020
CZ21.10.2020
ES21.10.2020
FI21.10.2020
HR21.10.2020
LT21.10.2020
LV21.10.2020
NL21.10.2020
PL21.10.2020
RO21.10.2020
RS21.10.2020
SE21.10.2020
SK21.10.2020
SM21.10.2020
BG21.01.2021
NO21.01.2021
GR22.01.2021
IS21.02.2021
PT22.02.2021
Former [2021/34]AT21.10.2020
CZ21.10.2020
ES21.10.2020
FI21.10.2020
HR21.10.2020
LT21.10.2020
LV21.10.2020
NL21.10.2020
PL21.10.2020
RS21.10.2020
SE21.10.2020
SM21.10.2020
BG21.01.2021
NO21.01.2021
GR22.01.2021
IS21.02.2021
PT22.02.2021
Former [2021/33]AT21.10.2020
ES21.10.2020
FI21.10.2020
HR21.10.2020
LT21.10.2020
LV21.10.2020
NL21.10.2020
PL21.10.2020
RS21.10.2020
SE21.10.2020
SM21.10.2020
BG21.01.2021
NO21.01.2021
GR22.01.2021
IS21.02.2021
PT22.02.2021
Former [2021/32]AT21.10.2020
ES21.10.2020
FI21.10.2020
HR21.10.2020
LV21.10.2020
NL21.10.2020
PL21.10.2020
RS21.10.2020
SE21.10.2020
SM21.10.2020
BG21.01.2021
NO21.01.2021
GR22.01.2021
IS21.02.2021
PT22.02.2021
Former [2021/30]AT21.10.2020
ES21.10.2020
FI21.10.2020
HR21.10.2020
LV21.10.2020
NL21.10.2020
PL21.10.2020
RS21.10.2020
SE21.10.2020
BG21.01.2021
NO21.01.2021
GR22.01.2021
IS21.02.2021
PT22.02.2021
Former [2021/28]AT21.10.2020
ES21.10.2020
FI21.10.2020
HR21.10.2020
LV21.10.2020
PL21.10.2020
RS21.10.2020
SE21.10.2020
BG21.01.2021
NO21.01.2021
GR22.01.2021
IS21.02.2021
PT22.02.2021
Former [2021/25]AT21.10.2020
ES21.10.2020
FI21.10.2020
LV21.10.2020
PL21.10.2020
RS21.10.2020
SE21.10.2020
BG21.01.2021
NO21.01.2021
GR22.01.2021
IS21.02.2021
PT22.02.2021
Former [2021/23]AT21.10.2020
FI21.10.2020
LV21.10.2020
RS21.10.2020
SE21.10.2020
BG21.01.2021
NO21.01.2021
GR22.01.2021
PT22.02.2021
Former [2021/22]FI21.10.2020
RS21.10.2020
NO21.01.2021
PT22.02.2021
Former [2021/21]FI21.10.2020
PT22.02.2021
Former [2021/20]FI21.10.2020
Cited inInternational search[XY]WO2014089487  (SHIRE HUMAN GENETIC THERAPIES [US]) [X] 1-56 * the whole document * * claims 1-12, 19-20, 32, 33, 34-43 * * pages 50-51, paragraphs [0170], [0172] * * examples 1, 2 * * pages 37-38, paragraphs [0133], [0134] * * page 46, paragraph [0159] * [Y] 1-56;
 [XP]  - JONES SIMON A ET AL, "A phase 1/2 study of intrathecal heparan-N-sulfatase in patients with mucopolysaccharidosis IIIA", MOLECULAR GENETICS AND METABOLISM, ACADEMIC PRESS, AMSTERDAM, NL, (20160510), vol. 118, no. 3, doi:10.1016/J.YMGME.2016.05.006, ISSN 1096-7192, pages 198 - 205, XP029617307 [XP] 1-56 * the whole document *

DOI:   http://dx.doi.org/10.1016/j.ymgme.2016.05.006
 [XY]  - Anonymous, "Safety, Tolerability, Ascending Dose and Dose Frequency Study of rhHNS Via an IDDD in MPS IIIA Patients - Full Text View - ClinicalTrials.gov", (20120928), URL: https://clinicaltrials.gov/ct2/show/NCT01155778, (20160909), XP055301294 [X] 1-5,8-12,14-49,51-56 * the whole document * [Y] 1-56
 [Y]  - Kathleen A. Delaney ET AL, "Methods of Neurodevelopmental Assessment in Children with Neurodegenerative Disease: Sanfilippo Syndrome", JIMD Reports - Volume 11, Berlin, Heidelberg, Springer Berlin Heidelberg, (20130101), vol. 13, pages 129 - 137, doi:10.1007/8904_2013_269, ISSN 2192-8304, ISBN 978-3-642-37328-2, XP055301391 [Y] 1-56 * the whole document *

DOI:   http://dx.doi.org/10.1007/8904_2013_269
 [YP]  - Anonymous, "NCT01047306 on 2016_03_29: ClinicalTrials.gov Archive", (20160329), URL: https://clinicaltrials.gov/archive/NCT01047306/2016_03_29, (20160909), XP055301420 [YP] 1-56 * the whole document *
 [Y]  - ELSA G. SHAPIRO ET AL, "Quantifying behaviors of children with Sanfilippo syndrome: The Sanfilippo Behavior Rating Scale", MOLECULAR GENETICS AND METABOLISM, AMSTERDAM, NL, (20150401), vol. 114, no. 4, doi:10.1016/j.ymgme.2015.02.008, ISSN 1096-7192, pages 594 - 598, XP055301513 [Y] 1-56 * the whole document *

DOI:   http://dx.doi.org/10.1016/j.ymgme.2015.02.008
 [Y]  - DAKOTA BUHRMAN ET AL, "Natural history of Sanfilippo syndrome type A", JOURNAL OF INHERITED METABOLIC DISEASE., NL, (20131123), vol. 37, no. 3, doi:10.1007/s10545-013-9661-8, ISSN 0141-8955, pages 431 - 437, XP055301524 [Y] 1-56 * the whole document *

DOI:   http://dx.doi.org/10.1007/s10545-013-9661-8
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.